SEC Form 4 · accession 0001209191-18-002712
AtriCure, Inc. · ATRC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
M. Andrew Wade
Officer — SVP and CFO
Period of report
Dec 29, 2017
Accepted (ET)
Jan 8, 2018 · 4:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001323885
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 29, 2017 | A | 571 | $15.50 | A | 162,521 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended December 31, 2017.
- F2Closing price on December 29, 2017 was $18.24.